Sentia Medical Sciences Inc. Announces Bente Hansen Ph.D. to Join Sentia Board
September 18, 2020
SAN DIEGO – Sentia announced today that Dr. Bente Hansen will join the Sentia Board. After earning a doctorate in Physiology from the University of Northern Colorado, Bente worked in the healthcare and life sciences industries before moving to the retained executive search industry. As Executive Director of the Executive Health Center at Scripps Memorial Hospital, she led operations and business expansion and guided the stress management program of the Center. She moved to EVP of Product Development and board member of HMG, a public cardiovascular company and VP of Business Development for Hygeia Pharmaceuticals, an early stage oncology company. For the past 20 years she has worked to bring executive leadership to life science companies as Vice President and Managing Director of DHR International, headquartered in Chicago, and West Coast Vice President and Managing Director for Gilbert Tweed based in New York before starting her company, Bente Hansen & Associates. Bente’s involvement has extended to numerous industry committees: The Salk Institute for Biological Sciences, Corporate Directors Forum, CONNECT, BIOCOM, and BIO. Bente is a member of WBL (Women Business Leaders) and Women in Bio. She was recognized by UCSD for her contribution to the Cancer Center. Her chapter on science recruitment was published in Alternative Careers in Science, in its second edition, and she has contributed to NextWave, an Internet career site for Science Magazine. She is the past Chairperson of the San Diego Chapter of the American Lung Association and the founding Chair of the Bioscience Affinity Group of Athena. Dr. Hansen has had a lifelong interest in the correlation between stress and disease.
“I am excited to join the Founders of Sentia to contribute my industry experience to helping the company continue its development. More than ever, there is such a significant need for this novel therapeutic in treating stress-related diseases. I am especially interested in the scientific focus of Sentia and I look forward to participating in and contributing to the company’s growth” said Bente Hansen.
“We are delighted to have Bente onboard with her extensive experience and connections in the biotechnology and pharmaceutical industry and we look forward to collectively working together to progress Sentia to the next phase” said Dominic Behan, CEO of Sentia.
About Sentia Medical Sciences Inc.
Sentia Medical Sciences Inc. is a privately held company with a vision to be the world leader in the development of novel peptide therapeutics to manage and cure stress-related diseases (www.sentiamedical.com).